| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
| Ausblick | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 98.34 |
| Pershing Square Capital Management LP | 3.86 |
| Pershing Square Holdings Ltd. | 3.45 |
| T Rowe Price Mid Cap Growth Fund | 1.57 |
| Pictet Asset Management Ltd. | 1.54 |
| BlueSpruce Investments LP | 0.54 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 13'500 | 14'800 | 16'300 | 16'400 | 17'000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.33 | 0.33 | 0.32 | 0.33 | 0.37 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 4'169 | 3'848 | 3'189 | 3'415 | 3'799 |
| Summe Anlagevermögen | 6'842 | 6'366 | 7'155 | 7'410 | 8'300 |
| Summe Aktiva | 8'426 | 8'541 | 9'452 | 9'627 | 10'705 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 2'011 | 1'799 | 2'407 | 2'537 | 2'911 |
| Summe Fremdkapital | 3'591 | 3'970 | 4'704 | 4'754 | 5'316 |
| Summe Eigenkapital | 4'835 | 4'571 | 4'748 | 4'873 | 5'389 |
| Summe Passiva | 8'426 | 8'541 | 9'452 | 9'627 | 10'705 |
Adresse
| 5301 Stevens Creek Boulevard, 95051 Santa Clara | |
| Telefon | +1 (800) 227-9770 |
| URL | http://www.agilent.com |
Management
|
Allison Ballmer
Senior VP-Strategy & Corporate Development |
|
Boon Hwee Koh
Non-Executive Chairman |
|
Brian Carothers
Vice President & GM, Nucleic Acid Solutions |
|
Daniel K. Podolsky
Independent Director |
|
Darlene J. S. Solomon
Chief Technology Officer & Senior Vice President |
|
David Hwang
Managing Director-Early Stage Partnership |
|
Dominique P. Grau
Senior Vice President-HR & Global Communications |
|
Dow R. Wilson
Independent Director |
|
George A. Scangos
Independent Director |
|
Guillermo Gualino
Treasurer & Vice President |
|
Hans Edgar Bishop
Independent Director |
|
Heidi Kunz Fields
Independent Director |
|
Henrik Ancher-Jensen
SVP & President-Order Fulfillment & Supply Chain |
|
Jacob Thaysen
SVP & President-Life Sciences & Applied Markets |
|
Jenipher E. Dalton
Senior VP-Global Quality & Regulatory Affairs |
|
John Palma
Vice President-Medical Affairs |
|
Katharine Knobil
Chief Medical Officer |
|
Kristin Giffin
Vice President & GM-Services & Support Division |
|
Lonnie G. Justice
Chief Marketing & Customer Experience Officer |
|
Mala Anand
Independent Director |
|
Michael R. McMullen
President, Chief Executive Officer & Director |
|
Michael Tang
Secretary, Senior Vice President & General Counsel |
|
Mikael Dolsten
Independent Director |
|
Otis W. Brawley
Independent Director |
|
Padraig Mcdonnell
President-Agilent Cross Lab Group |
|
Robert W. McMahon
Chief Financial Officer & Senior Vice President |
|
Rodney Gonsalves
Chief Accounting Officer, VP & Controller |
|
Samraat S Raha
SVP & President-Diagnostic & Genomics Group |
|
Stephen Bonovich
Vice President-Global Taxation |
|
Sue H. Rataj
Independent Director |